As a specialist in industrial biotechnology, we develop customized B2B solutions for industry. Our customers come from the food, chemical, health and cosmetics industries, among others.
What we’re really good at:
We are good at finding
In the search for suitable product candidates (microorganisms, enzymes or natural substances), we use an extensive collection of natural resources and metagenome libraries (BRAIN BioArchive) within the BRAIN Group.
If a particular enzyme is not found in the BRAIN Group’s enzyme portfolio, our metagenome libraries are the basis for our sequence- or activity-based search for new enzymes.
Our subsidiary Analyticon Discovery is a specialist in natural product chemistry and in the high-throughput isolation of natural products from various biological resources. Promising bioactive candidates (BRAIN BioActives) are characterized in more detail and researched further.
We find microorganisms with specific properties, for example, in the BRAIN BioArchive. We develop them further so that they can be used as functional biomass for industrial production processes or as high-performance production organisms.
We know all about expression systems
Construction of microbial expression systems: Our microbiologists and molecular biologists are highly experienced in constructing suitable microbial expression systems, which can then be used to produce proteins and enzymes on an industrial scale. For the expression of a "gene of interest" encoding a candidate enzyme or protein, the gene is inserted into an expression host.
Variety of expression strains: For the production of enzymes and proteins, we access a variety of expression strains, based on prokaryotic host organisms (including Escherichia coli, Bacillus subtilis, Pseudomonas stutzeri, Streptomyces lividans) and eukaryotic host organisms (including Pichia pastoris, Kluyveromyces lactis, Aspergillus niger).
Verification of production performance and targeted strain development: With the help of our bioinformatics and bioprocess technology experts, we generate basic strains in a short time to test the production performance and thus the suitability of an expression system. Subsequently, the production yield is maximized via directed and/or random strain development.
Optimize wild-type producers: In addition to heterologous protein and enzyme production, our experts also optimize wild-type producers by "evolution in the lab" and subsequently screen the generated diversity in high-throughput processes to identify enhanced producers.
We are experienced in application
We select the most suitable prokaryotic and eukaryotic expression strains for the economic production of enzymes and biocatalysts. If necessary, we use precisely designed strains and novel synthesis routes for high-value industrial production processes.
On request, we optimize enzymes already used by our customers to better meet complex process and application requirements.
Our experience with activity- and sequence-based screening (e.g. in the form of biochemical or cell-based assays) accelerates our search for bioactive substances.
Our customers benefit from the know-how of the entire BRAIN Group: in optimizing the biological effect of natural products; in testing the stability of enzymes and production strains; and in the formulation of custom-fit applications.
We can quickly develop strains in a targeted manner
Whether the aim is to obtain higher yields, more stable production strains or alternative substrates: we develop our microorganism strains to meet our customers' requirements. Among other things, we use our proprietary genome editing technology (CRISPR-Cas9-independent BEC technology) to achieve the desired result faster and in a more targeted manner.
From laboratory scale to process: we have the know-how
The step from laboratory scale to pre-industrial or industrial scale requires knowledge of process development and process optimization. The experienced engineers of the BRAIN Group contribute this knowledge during scale-up and tech transfer, among other things. Many of the processes we have developed have already been implemented in companies.
This is what distinguishes us as a biotechnology service provider:
We set ourselves high standards: We support customers in their endeavors to innovate and stand out from competitors.
Mainstreaming sustainability: As a pioneer in industrial biotechnology, the idea of using our solutions to ensure greater sustainability in the customer's company is firmly anchored in our minds. In many places, we have already been able to support our customers in achieving SDGs.
Outside-the-box thinking: We work in a cross-disciplinary manner and are creative when it comes to exploring previously unobtainable solutions.
Customer goals in mind: We understand, for example, the importance of fast time to market and help to shorten it based on our agility and experience.
Combining theory and practice: Besides our broad biotech expertise, one of the things customers appreciate about us is our application know-how and the experience we bring to process development.
We have successfully completed more than 150 joint R&D projects together with major international companies, and we know that a customized partnership model can be key to every successful innovation.
We provide support to our business partners with:
Our portfolio of B2B products
The BRAIN Biotech Group offers around 230 specialty products for B2B. This portfolio is constantly fueled by project realizations from our New Business Development pipeline.
The development of tailor-made solutions
Such industrial partnerships for specific tasks can either be based on milestone payments or on other research performance compensations, agreed in advance and usually implemented as exclusive R&D collaboration projects.
Get in touch
You want to find the right product for your needs, learn more about our innovative products or join in on an R&D partnership? Contact us today. We will find the right approach matching your need.